Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Casalegno Garduo, R ^a,b   Meier, C ^a   Schmitt, A ^a,b   Spitschak, A ^a   Hilgendorf, I ^a   Rohde, S ^a   Hirt, C ^c   Freund, M ^a   Putzer B M ^a   Schmitt, M ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; LEUKEMIA ANTIGEN; RECEPTOR FOR HYALURONAN ACID MEDIATED MOTILITY; RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; HERMES ANTIGEN; HYALURONAN MEDIATED MOTILITY RECEPTOR; HYALURONAN-MEDIATED MOTILITY RECEPTOR; SCLEROPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY;

ANTIGENS, CD44; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION, GENETIC;

EID: 84863672089     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/146463     Document Type: Article

References (35)

1. Casalegno-Garduo R., Schmitt A., Schmitt M., Clinical peptide vaccination trials for leukemia patients Expert Review of Vaccines 2011 10 6 785 799
2. Schmitt M., Schmitt A., Rojewski M. T., Chen J., Giannopoulos K., Fei F., Yu Y., Gtz M., Heyduk M., Ritter G., Speiser D. E., Gnjatic S., Guillaume P., Ringhoffer M., Schlenk R. F., Liebisch P., Bunjes D., Shiku H., Dohner H., Greiner J., RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses Blood 2008 111 3 1357 1365 (Pubitemid 351213422)
3. Rezvani K., PR1 vaccination in myeloid malignancies Expert Review of Vaccines 2008 7 7 867 875
4. Greiner J., Li L., Ringhoffer M., Barth T. F. E., Giannopoulos K., Guillaume P., Ritter G., Wiesneth M., Dhner H., Schmitt M., Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8 + T cells of HLA-A2-positive patients with acute myeloid leukemia Blood 2005 106 3 938 945 (Pubitemid 41076438)
5. Distler E., Wlfel C., Khler S., Nonn M., Kaus N., Schnrer E., Meyer R. G., Wehler T. C., Huber C., Wlfel T., Hartwig U. F., Herr W., Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8 + CD62L (high)+ T cells of healthy donors prevent AML engraftment in NOD/SCID IL2R null mice Experimental Hematology 2008 36 4 451 463
6. Chen J., Schmitt A., Chen B., Rojewski M., Reler V., Fei F., Yu Y., Yu X., Ringhoffer M., Von Harsdorf S., Greiner J., Gtzz M., Guillaume P., Dhner H., Bunjes D., Schmitt M., Nilotinib hampers the proliferation and function of CD8 + T lymphocytes through inhibition of T cell receptor signalling Journal of Cellular and Molecular Medicine 2008 12 5B 2107 2118
7. Turley E. A., Purification of a hyaluronate-binding protein fraction that modifies cell social behavior Biochemical and Biophysical Research Communications 1983 108 3 1016 1024 (Pubitemid 13072654)
8. Till K. J., Zuzel M., Cawley J. C., The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues Cancer Research 1999 59 17 4419 4426 (Pubitemid 29418763)
9. Tolg C., Hamilton S. R., Nakrieko K. A., Kooshesh F., Walton P., McCarthy J. B., Bissell M. J., Turley E. A., Rhamm -/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair Journal of Cell Biology 2006 175 6 1017 1028 (Pubitemid 44969206)
10. Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., Savani R. C., Kumar S., Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways Matrix Biology 2007 26 1 58 68 (Pubitemid 46091650)
11. Gao F., Yang C. X., Mo W., Liu Y. W., He Y. Q., Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing Clinical and Investigative Medicine 2008 31 3 E106 E116
12. Hall C. L., Yang B., Yang X., Zhang S., Turley M., Samuel S., Lange L. A., Wang C., Curpen G. D., Savani R. C., Greenberg A. H., Turley E. A., Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation Cell 1995 82 1 19 28
13. Nagy J. I., Hacking J., Frankenstein U. N., Turley E. A., Requirement of the hyaluronan receptor RHAMM in neurite extension and motility as demonstrated in primary neurons and neuronal cell lines Journal of Neuroscience 1995 15 1 241 252
14. Hall C. L., Lange L. A., Prober D. A., Zhang S., Turley E. A., pp60(c-src) is required for cell locomotion regulated by the hyaluronan receptor RHAMM Oncogene 1996 13 10 2213 2224 (Pubitemid 26411572)
15. Naor D., Nedvetzki S., Walmsley M., Yayon A., Turley E. A., Golan I., Caspi D., Sebban L. E., Zick Y., Garin T., Karussis D., Assayag-Asherie N., Raz I., Weiss L., Slavin S., Golan I., CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice Annals of the New York Academy of Sciences 2007 1110 233 247 (Pubitemid 350043012)
16. Buganim Y., Rotter V., RHAMM in the complex p53 cell cycle network Cell Cycle 2008 7 21 3291
17. Rein D. T., Roehrig K., Schndorf T., Lazar A., Fleisch M., Niederacher D., Bender H. G., Dall P., Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis Journal of Cancer Research and Clinical Oncology 2003 129 3 161 164 (Pubitemid 36583696)
18. Assmann V., Marshall J. F., Fieber C., Hofmann M., Hart I. R., The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells Journal of Cell Science 1998 111 12 1685 1694 (Pubitemid 28330555)
19. Amann V., Kern H. F., Elssser H. P., Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells Clinical Cancer Research 1996 2 9 1607 1618 (Pubitemid 126447457)
20. Li H., Guo L., Li J. W., Liu N., Qi R., Liu J., Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression International Journal of Oncology 2000 17 5 927 932
21. Teder P., Bergh J., Heldin P., Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines Cancer Research 1995 55 17 3908 3914
22. Ahrens T., Assmann V., Fieber C., Termeer C. C., Herrlich P., Hofmann M., Simon J. C., CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation Journal of Investigative Dermatology 2001 116 1 93 101 (Pubitemid 32108758)
23. Crainie M., Belch A. R., Mant M. J., Pilarski L. M., Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants Blood 1999 93 5 1684 1696 (Pubitemid 29102497)
24. Greiner J., Ringhoffer M., Taniguchi M., Schmitt A., Kirchner D., Krhn G., Heilmann V., Gschwend J. U., Bergmann L., Dhner H., Schmitt M., Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia Experimental Hematology 2002 30 9 1029 1035 (Pubitemid 35286619)
25. Greiner J., Ringhoffer M., Taniguchi M., Hauser T., Schmitt A., Dhner H., Schmitt M., Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia International Journal of Cancer 2003 106 2 224 231 (Pubitemid 36835175)
26. Wang C., Thor A. D., Moore D. H., Zhao Y., Kerschmann R., Stern R., Watson P. H., Turley E. A., The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression Clinical Cancer Research 1998 4 3 567 576 (Pubitemid 28193554)
27. Tzankov A., Strasser U., Dirnhofer S., Menter T., Arber C., Jotterand M., Rovo A., Tichelli A., Stauder R., Gnthert U., In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival Annals of Hematology 2011 90 8 901 909
28. Li L., Reinhardt P., Schmitt A., Barth T. F. E., Greiner J., Ringhoffer M., Dhner H., Wiesneth M., Schmitt M., Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens Cancer Immunology, Immunotherapy 2005 54 7 685 693 (Pubitemid 40884165)
29. Greiner J., Schmitt A., Giannopoulos K., Rojewski M. T., Gtz M., Funk I., Ringhoffer M., Bunjes D., Hofmann S., Ritter G., Dhner H., Schmitt M., High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma Haematologica 2010 95 7 1191 1197
30. Giannopoulos K., Dmoszynska A., Kowal M., Rolinski J., Gostick E., Price D. A., Greiner J., Rojewski M., Stilgenbauer S., Dhner H., Schmitt M., Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8 + T-cell responses in patients with chronic lymphocytic leukemia Leukemia 2010 24 4 798 805
31. Greiner J., Ringhoffer M., Taniguchi M., Li L., Schmitt A., Shiku H., Dhner H., Schmitt M., mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies International Journal of Cancer 2004 108 5 704 711 (Pubitemid 38076402)
32. Schmid C., Schleuning M., Schwerdtfeger R., Hertenstein B., Mischak-Weissinger E., Bunjes D., Harsdorf S. V., Scheid C., Holtick U., Greinix H., Keil F., Schneider B., Sandherr M., Bug G., Tischer J., Ledderose G., Hallek M., Hiddemann W., Kolb H. J., Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation Blood 2006 108 3 1092 1099 (Pubitemid 44154650)
33. Seggewiss R., Loré K., Greiner E., Magnusson M. K., Price D. A., Douek D. C., Dunbar C. E., Wiestner A., Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner Blood 2005 105 6 2473 2479 (Pubitemid 40387048)
34. Chen J., Schmitt A., Giannopoulos K., Chen B., Rojewski M., Dhner H., Bunjes D., Schmitt M., Imatinib impairs the proliferation and function of CD4 + CD25 + regulatory T cells in a dose-dependent manner International Journal of Oncology 2007 31 5 1133 1139
35. Mazo I. B., Honczarenko M., Leung H., Cavanagh L. L., Bonasio R., Weninger W., Engelke K., Xia L., McEver R. P., Koni P. A., Silberstein L. E., Von Andrian U. H., Bone marrow is a major reservoir and site of recruitment for central memory CD8 + T cells Immunity 2005 22 2 259 270 (Pubitemid 40255716)